Literature DB >> 29283973

Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.

Bruno K Podesser1,2, Maximilian Kreibich1,3, Elda Dzilic1,4, David Santer1,5, Lorenz Förster6, Sandra Trojanek6, Dietmar Abraham6, Martin Krššák7, Klaus U Klein8, Eva V Tretter8, Christoph Kaun1, Johann Wojta1, Barbara Kapeller1, Inês Fonseca Gonçalves1, Karola Trescher1,2, Attila Kiss1.   

Abstract

AIMS: Left ventricular (LV) hypertrophy is characterized by cardiomyocyte hypertrophy and interstitial fibrosis ultimately leading to increased myocardial stiffness and reduced contractility. There is substantial evidence that the altered expression of matrix metalloproteinases (MMP) and Tenascin-C (TN-C) are associated with the progression of adverse LV remodeling. However, the role of TN-C in the development of LV hypertrophy because of chronic pressure overload as well as the regulatory role of TN-C on MMPs remains unknown. METHODS AND
RESULTS: In a knockout mouse model of TN-C, we investigated the effect of 10 weeks of pressure overload using transverse aortic constriction (TAC). Cardiac function was determined by magnetic resonance imaging. The expression of MMP-2 and MMP-9, CD147 as well as myocardial fibrosis were assessed by immunohistochemistry. The expression of TN-C was assessed by RT-qPCR and ELISA. TN-C knockout mice showed marked reduction in fibrosis (P < 0.001) and individual cardiomyocytes size (P < 0.01), in expression of MMP-2 (P < 0.05) and MMP-9 (P < 0.001) as well as preserved cardiac function (P < 0.01) in comparison with wild-type mice after 10 weeks of TAC. In addition, CD147 expression was markedly increased under pressure overload (P < 0.01), irrespectively of genotype. TN-C significantly increased the expression of the markers of hypertrophy such as ANP and BNP as well as MMP-2 in H9c2 cells (P < 0.05, respectively).
CONCLUSION: Our results are pointed toward a novel signaling mechanism that contributes to LV remodeling via MMPs upregulation, cardiomyocyte hypertrophy as well as myocardial fibrosis by TN-C under chronic pressure overload.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29283973     DOI: 10.1097/HJH.0000000000001628

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  18 in total

Review 1.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

2.  Concomitant elevated serum levels of tenascin, MMP-9 and YKL-40, suggest ongoing remodeling of the heart up to 3 months after cardiac surgery after normalization of the revascularization markers.

Authors:  Da Liu; Danyal Ghani; Justin Wain; Wilson Y Szeto; Krzysztof Laudanski
Journal:  Eur J Med Res       Date:  2022-10-21       Impact factor: 4.981

Review 3.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

4.  The expression and role of tenascin C in abdominal aortic aneurysm formation and progression.

Authors:  Felix Nagel; Anne-Kristin Schaefer; Inês Fonseca Gonçalves; Eylem Acar; Andre Oszwald; Philipp Kaiser; Renate Kain; Karola Trescher; Wolf H Eilenberg; Christine Brostjan; David Santer; Attila Kiss; Bruno K Podesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

5.  Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice.

Authors:  David Santer; Felix Nagel; Inês Fonseca Gonçalves; Christoph Kaun; Johann Wojta; Miklós Fagyas; Martin Krššák; Ágnes Balogh; Zoltán Papp; Attila Tóth; Viktor Bánhegyi; Karola Trescher; Attila Kiss; Bruno K Podesser
Journal:  ESC Heart Fail       Date:  2020-07-08

6.  Tenascin-C: an emerging prognostic biomarker in diabetes.

Authors:  Saori Yonebayashi; Kazuko Tajiri; Siqi Li; Akira Sato
Journal:  Ann Transl Med       Date:  2020-12

7.  Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C.

Authors:  Saori Yonebayashi; Kazuko Tajiri; Mari Hara; Hiromitsu Saito; Noboru Suzuki; Satoshi Sakai; Taizo Kimura; Akira Sato; Akiyo Sekimoto; Satoshi Fujita; Ryuji Okamoto; Robert J Schwartz; Toshimichi Yoshida; Kyoko Imanaka-Yoshida
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 8.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

Review 9.  Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases.

Authors:  Kaj E C Blokland; Simon D Pouwels; Michael Schuliga; Darryl A Knight; Janette K Burgess
Journal:  Clin Sci (Lond)       Date:  2020-10-30       Impact factor: 6.124

10.  Cardiovascular phenotype of the Dmdmdx rat - a suitable animal model for Duchenne muscular dystrophy.

Authors:  Petra Lujza Szabó; Janine Ebner; Xaver Koenig; Ouafa Hamza; Simon Watzinger; Sandra Trojanek; Dietmar Abraham; Hannes Todt; Helmut Kubista; Klaus Schicker; Séverine Remy; Ignacio Anegon; Attila Kiss; Bruno K Podesser; Karlheinz Hilber
Journal:  Dis Model Mech       Date:  2021-02-22       Impact factor: 5.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.